Hackensack University Medical Center Foundation Receives Donation to Advance Multiple Myeloma Research

October 26, 2017

The Hackensack University Medical Center Foundation has received a substantial donation from Celgene Corporation to advance multiple myeloma research and transformational medicine that improve patient outcomes at John Theurer Cancer Center at Hackensack University Medical Center. Supported by Celgene, a global biopharmaceutical leader in the discovery, development and delivery of treatment for diseases like multiple myeloma, funds will help to establish the Multiple Myeloma Institute – a leading-edge research facility at the Hackensack Meridian School of Medicine at Seton Hall University scheduled to open in 2018. (This story was also featured by TapInto.)

Read full article on tapinto.net.